Core Viewpoint - The announcement of share reduction plans by the major shareholders of Gongdong Medical indicates a potential liquidity event, with a total of up to 6,614,787 shares, or 3% of the total share capital, set to be sold within the next three months [1][2] Shareholder Reduction Plans - The controlling shareholder, Shi Huiyong, plans to reduce holdings by up to 4,409,858 shares, which is 2% of the total share capital, through block trading [1] - Taizhou Jincheng Investment Management Partnership intends to reduce holdings by up to 2,204,929 shares, or 1% of the total share capital, via centralized bidding [1] - Combined, the two shareholders will reduce a total of up to 6,614,787 shares, representing 3% of the total share capital [1] Financial Implications - Based on the closing price of 19.38 yuan on September 4, the total cashing out from the planned reductions is approximately 128,194,572.06 yuan [2] - As of the announcement date, Shi Huiyong holds 110,836,040 shares (50.27% of total shares), while Jincheng Investment holds 14,258,009 shares (6.47% of total shares) [2] Shareholding Structure - Shi Huiyong, Shi Yibei, and Jincheng Investment collectively hold 141,558,049 shares, accounting for 64.21% of the total share capital [2] - Jincheng Investment is an employee stock ownership platform, and Shi Huiyong will not participate in this reduction [2] Previous Reduction Activities - Shi Huiyong has previously reduced his holdings by 3,151,400 shares, cashing out approximately 80.36 million yuan [4] - Jincheng Investment has also reduced its holdings by 1,575,700 shares, with a total cashing out of about 43.56 million yuan [5][6] - The cumulative cashing out by both shareholders amounts to approximately 123.92 million yuan [6]
拱东医疗实控人等拟减持套现1.3亿 此前已套现1.2亿